Literature DB >> 28489693

DYSFUNCTIONAL AUTONOMIC REGULATION OF THE CHOROID IN CENTRAL SEROUS CHORIORETINOPATHY.

C Nathaniel Roybal1,2, Elisabeth Sledz2, Yasser Elshatory3, Li Zhang4,5, David R P Almeida6, Eric K Chin7, Brice Critser4,5,8, Michael D Abramoff4,5,8, Stephen R Russell4,5,8.   

Abstract

PURPOSE: To study the effect of changing perfusion pressures on retinal and choroidal structure in central serous chorioretinopathy (CSC).
METHODS: This prospective observational case series included seven healthy volunteers (14 eyes) and seven patients (14 eyes) with CSC. Each patient underwent spectral domain optical coherence tomography with enhanced depth imaging in the upright (sitting) and supine positions. Image segmentation focused on central macular thickness, subretinal fluid, total macular volume, choroidal thickness, and choriocapillaris thickness. Blood pressure and heart rate were measured in the upright and supine positions.
RESULTS: Choriocapillaris thickness was thicker in CSC participants (34.23 μm; range, 30.9-36.5 μm) compared with healthy controls (13.96 μm; range, 7.15-23.87 μm) (P ≤ 0.001). The choroid was similarly thicker in CSC participants (371.4 μm; range, 200.2-459.4 μm) compared with healthy controls (231.4 μm; range 161.8-287.5 μm) (P ≤ 0.001). Choroidal thickness increased in patients with CSC when transitioning from upright (371.4 μm) to supine (377.8 μm) (P ≤ 0.01). By contrast, there was an 11.97% decrease in choroid thickness in normal controls when transitioning from upright (231.4 μm) to supine (203.9 μm). There were no significant hemodynamic changes.
CONCLUSION: We demonstrated that choroidal thickness increased in response to increased perfusion pressures in patients with CSC and not in normal controls. These findings likely represent an autonomic dysregulation of choroidal blood flow in patients with CSC.

Entities:  

Mesh:

Year:  2018        PMID: 28489693     DOI: 10.1097/IAE.0000000000001677

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  4 in total

1.  Risk factors of persistent subretinal fluid after half-dose photodynamic therapy for treatment-naïve central serous chorioretinopathy.

Authors:  Mengyang Li; Jinfeng Qu; Zhiqiao Liang; Jiyang Tang; Jie Hu; Yuou Yao; Enzhong Jin; Xiaoxin Li; Mingwei Zhao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-01-13       Impact factor: 3.117

2.  A pilot study of scleral thickness in central serous chorioretinopathy using anterior segment optical coherence tomography.

Authors:  Yun Ji Lee; Yeon Jeong Lee; Jae Yeon Lee; Suhwan Lee
Journal:  Sci Rep       Date:  2021-03-12       Impact factor: 4.379

3.  Relationship of Choroidal Vasculature and Choriocapillaris Flow With Alterations of Salivary α-Amylase Patterns in Central Serous Chorioretinopathy.

Authors:  Fabio Scarinci; Francesca Romana Patacchioli; Eliana Costanzo; Mariacristina Parravano
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-12-01       Impact factor: 4.925

4.  Investigation of Serum and Macular Carotenoids in Central Serous Chorioretinopathy.

Authors:  Yuying Ji; Yuhong Gan; Yongyue Su; Yining Zhang; Miaoling Li; Lan Mi; Chengguo Zuo; Feng Wen
Journal:  Front Med (Lausanne)       Date:  2022-04-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.